1. Fernandez A, Lichtshein G, Vieweg WV. The Charles Bonnet syndrome: a review. J Nerv Ment Dis. 1997; 185:195–200.
Article
2. Menon GJ, Rahman I, Menon SJ, Dutton GN. Complex visual hallucinations in the visually impaired: the Charles Bonnet syndrome. Surv Ophthalmol. 2003; 48:58–72.
3. Podoll K, Osterheider M, Noth J. The Charles Bonnet syndrome. Fortschr Neurol Psychiatr. 1989; 57:43–60.
4. Burke W. The neural basis of Charles Bonnet hallucinations: a hypothesis. J Neurol Neurosurg Psychiatry. 2002; 73:535–41.
Article
5. Damas‐ Mora J, Skelton‐ Robinson M, Jenner FA. The Charles Bonnet syndrome in perspective. Psychol Med. 1982; 12:251–61.
6. Gold K, Rabins PV. Isolated visual hallucinations and the Charles Bonnet syndrome: a review of the literature and presentation of six cases. Compr Psychiatry. 1989; 30:90–8.
Article
7. Maloof AJ. Phantom vision: A graphic description. Ophthal Plast Reconstr Surg. 2004; 20:80–1.
Article
8. Pliskin NH, Kiolbasa TA, Towle VL, et al. Charles Bonnet syndrome: an early marker for dementia? J Am Geriatr Soc. 1996; 44:1055–61.
Article
9. Lang UE, Stogowski D, Schulze D, et al. Charles Bonnet Syndrome: Successful treatment of visual hallucinations due to vision loss with selective serotonin reuptake inhibitors. J Psychopharmacol. 2007; 21:553–5.
10. Coletti MM, Milano E, Gasverde S, et al. Olanzapine therapy in hallucinatory visions related to Bonnet syndrome. Neurol Sci. 2005; 26:168–70.
Article
11. Hori H, Terao T, Shiraishi Y, Nakamura J. Treatment of Charles Bonnet syndrome with valproate. Int Clin Psychopharmacol. 2000; 15:117–9.
Article